We investigate how characteristics of sleep-wake dynamics in humans are modified by narcolepsy, a clinical condition that is supposed to destabilize sleep-wake regulation. Subjects with and without cataplexy are considered separately. Differences in sleep scoring habits as a possible confounder have been examined. Aims and Methods: Four groups of subjects are considered: narcolepsy patients from China with (n = 88) and without (n = 15) cataplexy, healthy controls from China (n = 110) and from Europe (n = 187, 2 nights each). After sleep-stage scoring and calculation of sleep characteristic parameters, the distributions of wake-episode durations and sleep-episode durations are determined for each group and fitted by power laws (exponent α) and by exponentials (decay time τ). Results: We find that wake duration distributions are consistent with power laws for healthy subjects (China: α = 0.88, Europe: α = 1.02). Wake durations in all groups of narcolepsy patients, however, follow the exponential law (τ = 6.2-8.1 min). All sleep duration distributions are best fitted by exponentials on long time scales (τ = 34-82 min).
INTRODUCTION
A degeneration of hypothalamic neurons producing orexin (hypocretin) is the primary cause of human narcolepsy, since low orexin-1 levels in cerebrospinal fluid have been detected in over 90% of the patients with cataplexy (NC) and in 40% without cataplexy (NWC). The loss of orexin neurons may also lead to behavioral state instability, with poor maintenance of wakefulness in daytime and impaired consolidation of sleep during nighttime. 1, 2 Disrupted nocturnal sleep is a common complaint in patients with narcolepsy, and polysomnography (PSG) studies consistently reveal frequent arousals, higher wake after sleep onset (WASO), frequent shifts to wake or increased N1 sleep, and overall decreased sleep efficiency. This is of clinical importance as sleep fragmentation can worsen other manifestations of narcolepsy, especially excessive daytime sleepiness (EDS). 3 The American Academy of Sleep Medicine (AASM) endorses disrupted nocturnal sleep as part of a narcolepsy symptom pentad and recommends controlling troublesome nocturnal symptoms of disrupted sleep in patients with narcolepsy to be a target of treatment.
In addition, altered sleep-stage transitions of REM sleep have a significant diagnostic value in the differential diagnosis of hypersomnias. 4 The occurrence of a sleep onset REM period (SOREMP) in the PSG has consequently been considered as an objective criterion in the International Classification of Sleep Disorders III (ICSD III, 2014). Medications may consolidate sleep and therefore improve daytime symptoms of EDS and cataplexy. 5 However, most previous studies focused on the stage sequence exclusively across the time windows of sleep onset. The analysis was based on conventional PSG sleep parameters obtained by visual scoring at a macrostructural level, which can provide only a static picture of sleep, thus missing its complexity and dynamic unfolding over time.
Ferri et al. 6 analyzed the time structure and complexity of the transitions between states in the whole major sleep period by applying the Markov chain model and reported a lower probability of REM-to-N2 transitions occurrence in type 1 narcolepsy. Simultaneous electroencephalographic (EEG) and functional magnetic resonance imaging studies on resting-state brain function in adolescents with predominantly type 1 narcolepsy revealed a significantly lower mean duration for microstate A, 7, 8 which suggests a disease-specific disruption of the anterior and posterior aspects of the default mode network and probably reflects a latent state instability. This makes wakefulness more susceptible to sleep in narcoleptics. However, narcolepsy patients may also show wake-like features in microstructural EEG during sleep, which reflects the intrusion of brain state characteristics of wakefulness into sleep. 9 These evidences indicate the necessity to study the stage transition patterns not only
Statement of Significance
Previous studies of sleep-wake transition dynamics in healthy humans and mammals revealed that the durations of wake episodes during the night follow power-law distributions, whereas the durations of sleep episodes follow exponential distributions. Here, we study these distributions in larger data sets from narcolepsy patients and healthy subjects. Comparing 4 groups, including data from narcolepsy patients with and without cataplexy and controls from Europe and China, we found that the wake duration distributions are consistent with power laws only for healthy subjects. Wake durations of narcolepsy patients and sleep durations for all subjects rather follow exponential distributions. These findings suggest that the control of wakefulness is altered in narcolepsy patients, reducing the frequency of long wake episodes.
between REM and non-REM (NREM) sleep but also between sleep and wakefulness.
Earlier studies of sleep-wake transition dynamics in healthy human adults by Lo et al. 10 investigated in particular 2 prototype distributions, namely (1) a power-law distribution, P i (t) = A t −α and (2) a single exponential distribution,
The values of the (scaling) exponent α in (1) and the characteristic decay time τ in (2) are relevant for the modeling of the dynamics of the respect ive state. In particular, if an exponential decay is observed, τ corresponds to the typical episode duration. For a power-law distribution (1), however, no typical episode duration exists. The probability of very short and very long episodes is increased (compared with the single exponential distribution), and the probability of ending the current (wake or sleep) episode decreases with t. This implies a control of the duration involving long-term memory, i.e., for each moment in time, the control system must "remember" the time spent since the beginning of the episode. Power-law distributions appear widely in nature. They are typically related to physical and physiological systems with controlled behavior with long-term memory. Possible underlying mechanisms include, but are not restricted to, (fractional) random walk processes and systems characterized by critical phenomena.
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In their seminal study, 10 Lo et al. revealed the surprising observation that the durations of wake episodes during the night follow the power-law distribution (1) . However, the durations of sleep episodes follow exponential distributions (2), which is supposedly generated by random (uncontrolled) dynamics with constant transition probabilities.
These initial findings 10 have been confirmed as a common phenomenon across mammalian species including mice, rats, and cats in combination with data from humans, 12 indicating that the unique coexistence of both scale-invariant and exponential processes might be a basic output of a single sleep regulatory mechanism at the system level that has not been observed in other integrated physiological systems under neural regulation. 13 Lo et al. 10 also proposed a first physiologically motivated stochastic model based on random walks, suggesting that differences in the dynamics of sleep and wake states arise from the constraints on the number of microstates in the sleep-wake system. Specifically, they established that the exponent α for wake durations relates to the restoring force to sleep (sleep inertia), whereas the time constant τ for sleep durations relates to the depth of sleep.
Studies in patients with sleep disorders due to fibromyalgia syndrome and chronic fatigue syndrome demonstrated that power-law distributions for the durations of wake episodes and exponential distributions for sleep episodes remained practically identical; 14,15 the only change was that power-law distributions for NREM episodes with a very small exponent α appeared in chronic fatigue syndrome.
Sleep apnea is the most studied sleep disorder in regard to sleep-wake transition dynamics. Although controversial findings were reported, [16] [17] [18] Lo et al. 13 confirmed that in patients with sleep apnea, the power-law behavior for arousal and wakefulness durations remains. While the asymmetry of sleep-stage transitions is affected, the form of the duration distributions is not altered-a major finding in agreement with their earlier work. 10, 12, 19 In narcolepsy, an increased number of transitions between all sleep stages was reported in previous studies. [6] [7] [8] [9] In the present study, the major goal was to analyze the effect of narcolepsy on sleep-wake dynamics, in particular wake-state duration distributions. This may contribute towards the development of a theoretical model for orexin-1 as a modulator of sleep-wake transitions. Besides orexin-1 per se, other factors such as brain development during adolescence [20] [21] [22] and inter-and inner-laboratory scoring agreement 23 may also influence the comparison of sleep-wake dynamics. Hence, a secondary goal of the current study was to illustrate if any of the differences existing between our narcoleptics and control groups were affected by those factors.
METHODS
Within our analysis, 4 groups of subjects are considered. Demographic data as well as common sleep parameters are given in Table 1 .
Narcolepsy with cataplexy group Na1: The patients had been referred to the sleep center of Beijing University People's Hospital. Evaluation procedures included nocturnal sleep recordings, Multiple Sleep Latency Test (MSLT), and Student Satisfaction Inventory (SSI) assessments. All these patients had the presence of clear cataplexy, sleep latency less than 8 min, and at least 2 episodes of SOREMP. To assess the influence of interrater variability, a subgroup of 27 recordings from Na1 has been rescored in 2015 by an experienced technician of Binzhou Medical College. The mean age of the patients in this subgroup is 14.8 ± 7.9 years, including 8 female patients. The original subgroup data are denoted as Na1S and the rescored subgroup data are denoted by Na1R in the following.
Narcolepsy without cataplexy group Na2: These patients had been referred to Beijing University People's Hospital, following the same examination and analysis protocol as group Na1. While they fulfill the same criteria regarding sleep latency and SOREM, no cataplexy was diagnosed in these patients.
Control group Co1 comprises 110 healthy subjects from 2 sleep laboratories in China. All subjects had voluntarily participated in the sleep examinations, encompassing MSLTs and nocturnal PSG. If the controls were of minor age, parents agreed in study participation. Sixty-six of the volunteers were examined in the sleep center of the Beijing University People's Hospital and 44 in the sleep center of Shandong Hospital. None of them had sleep disorders or other health issues.
Control group Co2 comprises 187 healthy subjects from a large European study (SIESTA). 24 Of note, previous studies 10, 12, 13, 19 analyzed subgroups of the database. The data were recorded in 8 European sleep laboratories (Berlin, Marburg, Mainz in Germany, Tampere in Finland, Den Haag in the Netherlands, Barcelona in Spain, and 2 laboratories in Vienna in Austria). All subjects gave informed consent, and the study was approved by the local ethics committees. General exclusion criteria were a history of drug abuse or habitation (including alcohol), psychoactive medication or other drugs, e.g., β-blockers, or night shift work. Subjects had no neurological, mental, medical, or cardiovascular disorders. During the study, the consumption of coffee, alcohol, and cigarettes was limited to each subject's habitual rate.
Comparing the mean ages of the different groups (c.f. Table 1) , the values in Na1, Na2, and Co1 are much lower than in Co2. To investigate age dependencies, we therefore consider 3 subgroups of Co2 with young subjects (Co2Y, ages 20-39 years, mean 29.0, n = 61), middle-aged subjects (Co2I, ages 40-59 years, mean 48.2, n = 59), and elderly subjects (Co2E, ages ≥ 60 years, mean 71.7, n = 67).
All subjects from the different groups and subgroups were examined by at least 1 overnight PSG. The recorded signals include at least 2 EEG leads, left and right electrooculographic leads and 2 submental electromyography (EMG) leads, anterior tibialis EMG, ECG, thoracic and abdominal effort belts, airflow using a nasal pressure transducer, and pulse oximetry. The PSGs of groups Na1, Na2, and Co1 have been scored by sleep technicians of the sleep center of Beijing University People's Hospital. As mentioned before, subgroup Na1R has been independently rescored in Binzhou Medical College. The AASM criteria from 2007 25 have been applied for scoring in both cases. The PSGs of group Co2 were scored by 2 independent experts from different laboratories of the SIESTA consortium, followed by a consensus scoring obtained from a third expert. Only the consensus scoring was used here. For Co2, the older Rechtschaffen & Kales rules were used. 26 For the calculation of the percentage of N3 of Co2 (see Table 1 ), NREM3 and NREM4 have been joined to sleep stage N3.
We would like to emphasize that the different scoring standards do not apply relevantly different scoring rules regarding wake states. As REM and NREM sleep stages are combined into an overall sleep state within our analysis, a direct comparison of the hypnograms obtained by the different scoring schemes is justified.
Using this simplified 2-state hypnogram, the time intervals between sleep onset and wake onset ("sleep durations") and between wake onset and sleep onset ("wake durations") are determined for each of the 4 groups of subjects. Initial and final wake states are not included into the analysis. Due to the time resolution of sleep scoring, all durations are multiples of the 30-s epoch length. Following Lo et al. 10 and others, we analyze the cumulative distributions P i (t), i = W,S of wake and sleep durations. P W (t) is defined as the number of wake durations equal to or longer than the duration t divided by the total number of wake durations, while P S (t) is the corresponding cumulative distribution for sleep. As a consequence, P W (0.5 min) = P S (0.5 min) = 1, since all episodes consist of at least one 30-s epoch. The values for t > 0.5 min are decreasing with time. To assess the underlying control mechanism, it is relevant to study how both functions decay with increasing values of t. In particular, different distribution functions indicated different dynamics. Both prototype distributions as described in the introduction are investigated, i.e, (1) power-law distribution and (2) exponential-law distribution.
The different distributions are visualized qualitatively by plotting P i (t) vs. duration t using different scales on the axes. In a double-logarithmic plot [log P i (t) vs. log t], power-law distributions (1) appear as straight lines with slopes of −α. In contrast, single exponential distributions result in a straight line with slope −1/τ in a semilogarithmic plot [i.e., log P i (t) vs. t]. Quantitatively, the data are fitted with both prototype distributions (1) and (2) , and the χ 2 fit error is calculated. For the power-law fit, the fit error is denoted as χ As for very large durations, the actual cumulative distribution values are statistically unstable due to a low number of samples, the fitting range is restricted to durations below 25 min for the wake state. In contrast to earlier studies, we also apply a lower limit of 2.5 min to the fitting range of the wake state.
As we found notably less short-term episodes scored in Na1, Na2, and Co1 than in Co2, we assume different scoring habits in the participating sleep laboratories. This was confirmed by the assessed interrater variability of 27 subjects from Na1 (see Appendix for more information about these differences). However, the fitting range still comprises 1 order of magnitude in time scales t, so that reliable fits are possible. For the sleep states, the episode durations are generally longer; so the fitting range for the sleep-episode durations is set to 15 min < t < 150 min, also encompassing 1 order of magnitude. Again, the lower limit is consistently a bit larger than duration limits around 5-10 min used in the previous studies of European data. 10, 12, 13, 19 The decision, which prototype distribution fits better, is made by the ratio of the corresponding fit errors of power-law distribution (1) and single exponential distribution (2) . For a ratio χ p /χ e smaller than unity, the power-law fit is better, whereas the exponential fit is better for a ratio larger than unity. Figure 1 shows the cumulative wake duration distributions P W (t) for all 5 groups. In panel (a) the double logarithmic presentation is used. We observe that the power-law fits describe well the data of Co1 and Co2, but large deviations (between fits, i.e., dashed lines, and data) occur for all groups of narcolepsy patients.
RESULTS

Wake-State Dynamics
The quantitative results, i.e., the values of the slopes α and the fit errors of all fits in the considered range of time scales t are reported in Table 2 . The fit errors for the healthy controls are about 1 order of magnitude lower than for the patient groups. For example, the fit error for control group Co1 is 0.0054, whereas the fit error for narcolepsy with cataplexy Na1 is 0.042. The value of the fitted scaling exponents α appear to be a bit smaller in the Chinese control group (α = 0.88) than in the European control group (α = 1.02). The results for the narcolepsy groups Na1 and Na2 are given in Table 2 for completeness. However, they should not be taken as meaningful, since power-law fit quality is poor for the narcolepsy groups. In Figure 1, (b) , the same data are presented in a semilogarithmic plot. The straight lines give the results of the fits based on the exponential distribution (2) . Here, the exponential fits seem rather suitable for all 3 narcolepsy groups, whereas the fits for the control groups show strong deviations. The fitting parameters τ are also shown in Table 2 . Instead of the fit errors, the ratios to the corresponding fit errors of the power-law distribution fits are given. We find that power-law fits are always better for the control groups (ratios 0.41 or smaller) and exponential fits are always better for the narcolepsy groups (ratios 1.9 or larger). Figure 2 shows the semilogarithmic plot of the sleep-state duration distributions [log P S (t) vs. t]. Again, the fits by P S (t) = B exp[−t/τ] appear as straight lines with slopes −1/τ (solid lines). It can be seen that the cumulative duration distributions for sleep episodes (all NREM stages and REM combined) can be well fitted by an exponential distribution for all 5 groups. The values of the characteristic decay times τ are given in Table 2 . A comparison of the fit errors for power-law fits and exponential fits indicates that the exponential fits are always better, since the corresponding ratios of fit errors are between 2.8 and 32.7 (Table 2) . Power law fits are therefore not shown. We note that exponential fits are particularly better for Co1 and the 3 subgroups of Co2 (yielding ratios larger than 10), while the ratio is less elevated in Co2 and in case of narcolepsy. Table 2 . Table 2 -Quantitative results of fitting power law P(t) = A t −α and exponential P(t) = B exp[−t/τ] distributions to the cumulative wake-and sleep-episode duration distributions for all 4 main groups and 5 subgroups. For the wake state, the scaling exponent α for the fit of P W (t) = A t −α as well as the fit error χ p in the regime 2.5 ≤ t/min ≤ 25 are given. The next column shows the characteristic decay time τ for exponential fits to P W (t) for the same fitting regime, The relative quality of the 2 fits is given as "error ratio" χ p /χ e ; that is the ratio of the power-law fit error to the corresponding exponential fit error. As for the sleep state exponential fits are always better, for the sleep-episode duration distributions P S (t) only the decay time τ for exponential fits in the regime 15 ≤ t/min ≤ 150 are given together with the corresponding error ratio. While the qualitative behavior is consistent in all groups, the quantitative values for τ, describing the mean sleep episode durations, differ strongly among the groups. First, we would like to emphasize the age dependency of τ. Comparing the subgroups of Co2, we observe decreasing τ with age, so the mean time between awakenings during the night decreases with age. The Chinese control group shows the largest characteristic decay time of τ = 81.9 min; all other decay times are lower. But the results are somehow inconsistent: the decay times of NaS and NaR differ markedly. While the originally scored data result in a higher mean episode duration (τ = 56.7 min) than the closest age group of the European controls (Co2Y, τ = 44.6 min), the rescored data show a lower decay time (τ = 33.8 min).
Sleep-State Dynamics
Relative mean sleep episode durations for the narcolepsy groups compared to Co1 and Co2 are given in Table 3 . While relative values are comparable for Na1, Na1S, and Na2, relative mean values for Na1R are nearly half the value. However, relative values of Na1S compared with Co1 and Na1R compared with Co2Y differ only by 10%.
DISCUSSION
We conclude that, in accordance with earlier work, for wake episodes power-law distributions fit the data of both groups of healthy controls much better than exponential distributions ( Figure 1 and Table 2 ). The power-law behavior for the distributions of wake durations suggests scale-invariant dynamics that are typical for fractal-like phenomena observed in systems undergoing phase transitions or self-organized criticality. 12, 13, 19 In contrast, the exponential fits are better for all 3 groups of narcolepsy patients, irrespective of the presence or absence of cataplexy. This observation may suggest that narcolepsy hinders the development of self-organized criticality in the wake-state control of the patients, so that a control mode with a specific time scale (as for the sleep durations) takes over.
Sleep-episode duration distributions, however, can always be fitted better by exponentials. While the qualitative results are consistent in the narcolepsy groups and the control groups respectively and are not influenced by age or inter-rater variability, the actual fitting parameters may differ notably. In particular, the characteristic decay time τ is affected by age and scoring habits.
We observe decreasing τ with age. This is in accordance with the age dependency of the WASO (WASO) value, describing the percentage of wake time during the sleep period. WASO has been found to increase mostly monotonically with age from a medium value of 2% in 20-year-old subjects to 16% for 80-yearold healthy controls, 27 based on Co2. The Chinese control group Co1, which is still younger than the youngest European age group Co2Y and matches the age of the narcolepsy groups better, shows a very long τ of 82 min. This value is nearly twice as long as for Co2Y. While a higher value is consistent with the lower age, the actual value is much higher, than one would expect by extrapolation of the obtained data from Co2. For example, a simple linear model would predict τ = 46 min, and a linear extrapolation would predict τ = 52 min. As we observe strong interrater variability regarding the scoring of short awakenings during the night (please refer to the Appendix), we suspect that differing scoring habits have led to a consistently lower scoring of short wake bouts in Co1, Na1, and Na2, compared to Co2. Interestingly, our previous study of international (ChineseGerman) inter-scorer comparisons for healthy subjects, sleep apnea patients, and narcolepsy patients, 23 where interrater reliability in scoring sleep stages was evaluated for sleep laboratories in Berlin (part of the SIESTA consortium) and Beijing (where Na1, Na2, and parts of Co1 had been scored), did not detect these scoring differences. Specifically, inter-laboratory epoch-by-epoch agreement comparison between scorers from the 2 countries yielded a moderate agreement. However, Na1R shows a significantly larger number of small bouts compared to the original scoring. Based on this fact, we think that the rescoring might be comparable to the consented scoring of the SIESTA study. This is supported by the fact that the relative values of Na1S compared with Co1 and Na1R compared with Co2Y differ only by about 10%. If we consider the slightly older control group of Co2Y, compared with Co1, the relative values of Na1S and Na1R are quite close. The relative value of Na1S compared with Co1 lies between relative values for Na1R compared to the abovementioned Co2 extrapolation values.
Apparently, skipping short wake episodes typically leads to prolonged sleep episodes. Hence, the values of τ around 22 min reported in the previous literature 10, 12, 19 can only be compared with our values for the European control group Co2 and its 3 subgroups, where we find τ = 33.6 min (and 44.6, 28.3, Tables 2 and 3 . Table 3 24.0 min, respectively) for our fitting regime. We note that relevant deviations from the ideal exponential law do clearly exist even in our restricted fitting regime (Figure 2 ), leading to not fully comparable τ values. The individual duration distributions for light sleep, deep sleep, and REM sleep episodes separately could not be fitted well by either power laws or single exponential distributions in our data sets (data not shown), although others 13, 17 report exponential fits with τ values around 10 min for them. However, the statistical power of such an analysis is expected to be weak, as the number of episodes of a specific sleep stage is typically less than the number of sleep states.
An increased number of sleep state transitions including sleep-wake transitions during nocturnal sleep is a well-established finding in narcolepsy, which may help in diagnosing this condition. 1, 28 The reduced values of τ in the exponential fitting of sleep durations as well as wake bouts in the narcolepsy samples compared to the controls scored with similar scoring habits indicate more rapid transitions and are therefore in accordance with this finding. Our results may also indicate that the sleep of narcolepsy patients is shallower than that of healthy subjects, since the parameter Δ in the sleep-wake dynamics model of Lo et al. 10 represents the range of accessible sleep depths (between −Δ and 0) and is related to our decay parameter τ via τ ~ Δ 2 . Our finding of an exponential distribution of wake bouts in narcolepsy, however, does not simply follow from an increased tendency for sleep-state transitions since it involves an altered distribution of episode lengths rather than a different scaling factor. Interestingly, in an animal model of narcolepsy, 29 a differential impact of orexin deficiency on wake bouts of different lengths was found. Using orexin knockout mice, this group found that orexins were necessary for the maintenance of long bouts of wakefulness, but orexin deficiency had little impact on wake bouts <1 min. Such a differential effect on long and short wake bouts is very likely to alter the characteristics of the distribution of wake episode durations. In particular, exponential distribution is associated with a decreased probability of short and long durations compared with power-law distribution. Thus, a reduction of long wake bouts due to orexin deficiency may result in better total exponential fitting although the probability of short wake episodes may not be decreased. However, the dynamics of very short wake episodes has not been investigated in our study, as different scoring habits may have a strong influence on the presence of such episodes in the hypnogram.
Our study is limited due to the data available. Since many of the narcolepsy patients are children, perfect age matching is challenging, as it is difficult to acquire a comparable number of minor volunteers. Therefore, the controls used are older. Furthermore, different scoring policies may result in different scoring of short sleep-stage episodes, thus resulting in different sleep-wake transition patterns.
While the qualitative changes and trends in the sleep-wake transition dynamics in narcolepsy patients could be reliably determined and have been shown to be robust against age and scoring habits, absolute measures like the mean sleep episode duration are more strongly dependent on age and on the chosen fitting range. A better age matching of the controls could reduce biases due to age dependencies of sleep-wake transitions. Consented sleep profiles with special attention on the detection of short stages of sleep and wake may extend the fitting range beyond 1 order of magnitude and may give further insight into the underlying mechanisms driving the sleep-wake dynamics, including different behavior on different time scales.
APPENDIX: INFLUENCE OF PRACTICES FOR SCORING SHORT EPISODES ON SLEEP-WAKE DURATION ANALYSIS
The quantitative analysis of sleep-wake transitions strongly relies on the temporal resolution of the scoring. Standard scoring is realized on the basis of 30-s epochs. Short intermediate wake states of 1 or 2 epochs' duration may not contribute much to the common sleep parameters, such as total sleep time or wake after sleep onset if longer wake episodes are also present. Hence, a deviating scoring of short wake bouts as sleep (or vice versa) may not be clinically relevant in most cases, as it does not alter strongly clinical sleep parameters. However, if sleep-wake transitions are scored with a lower temporal resolution of a minute or lower, this affects the numbers and duration distributions of both sleep and wake episodes, since the frequency of shortterm episodes is underestimated. In addition, longer episodes appear, as 2 episodes of the same state are no longer interrupted by a short-term transition to the other state, but considered as a single episode. While the trend is obvious, the actual relevance of the effect is difficult to estimate; it may also depend on the underlying "true" distribution model of sleep-and wake-state durations.
The number of awakenings after sleep onset (NASO) can be regarded as a quantitative measure to describe sleep-wake transitions, while the total number of transitions (TRANS) also includes transitions between different sleep stages. Independent scoring of 27 narcolepsy patients by different sleep laboratories (see Methods) resulted in strongly differing values for NASO and TRANS. While the original scoring showed an average NASO of 9.9 and a mean TRANS of 49.1, the rescoring resulted in an average NASO of 23.3 and a mean TRANS of 118.4. Both values increased by more than a factor of 2 by rescoring. This indicates a consistent overlooking of short-term episodes in the original scoring. However, the percentage of each sleep stage of the total sleep period does not differ significantly, nor does the sleep efficiency index (data not shown). This indicates that there is indeed a large number of differently scored sleep-stage episodes (given by the strongly differing NASO and TRANS), but that these episodes encompass only a short fraction of the total sleep period. This finding is also confirmed by the nearly constant cumulative numbers of wake episodes of 1-2 epoch length in the Chinese control group Co1, i.e. ≤1 min duration (see Figure 1 , A). In contrast, the distribution of wake episodes in Co2 shows a strong decrease between 1-and 2-epoch wake-state cumulative numbers, in accordance with the power-law distribution of wake-state durations.
If we simplify the effect of the different scoring to a lower temporal resolution by a factor of 2, thus resulting in an overall doubled length of the episodes, the distribution should still reflect the underlying regulation mechanism qualitatively. However, the number of episodes is only half of the number of "fully resolved" episodes, reducing the statistical power of the fit. In particular, the fitting range is reduced, as the shortterm episodes are missing and the long-term episodes are less frequent due to the overall reduced number of episodes. For the fitting of power-law distributions, the logarithm of the wake duration is taken. A factor of 2 would only add a constant of log(2) ≈ 0.3 to the wake durations. This would leave the slope of the linear fit unchanged, but the intercept would be increased. Actually, the mean NASO for Co1 is found to be 5.6, while a value of 23 is measured for Co2, resulting in a more than 3 times higher number of sleep-wake transitions in the European control group. With a number of 374 analyzed PSGs in Co2, the total number of wake episodes is 8602, while the 110 subjects in Co1 yield a total of 616 wake episodes. Keeping the weaker statistics of Co1 in mind, the observed values for α in Co1 and Co2 are comparable, with a notably higher intercept for Co1.
For the exponential distribution fit, however, the axis of the duration is scaled linearly. Here, a factor of 2 in the durations would actually result in half the slope, and therefore in a doubled value of τ. Indeed, the fitted τ is higher in Na1S than in Na1R; and it is higher in Co1 than in Co2. While showing a factor 2.3 in the NASO value, τ is increased by 1.65 for the wake states and 1.68 for the sleep states. For the control groups, the ratio of NASO of 1.8 results in an increase of τ by a factor 2.4.
However, the simplified model of a consistent coarser scoring is idealized. In all groups, short-term sleep and wake episodes are present, even if NASO is strongly reduced. A stage-specific overlooking of short-term episodes is very likely, where, e.g., short sleep states are more frequently detected, whereas short wake states are missed. However, if consistently scored, the distribution should still follow the underlying regulation mechanism, but the fit parameters would change.
